Decoding 12 Analyst Evaluations For Capricor Therapeutics
Decoding 12 Analyst Evaluations For Capricor Therapeutics
解讀12位分析師對capricor therapeutics的評價
The perception...Analysts' ratings for Capricor Therapeutics (NASDAQ:CAPR) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
分析師對於Capricor therapeutics（納斯達克：CAPR）在過去一個季度的評級從看好到看淡不等，來自12位分析師的提供。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
Analysts have set 12-month price targets for Capricor Therapeutics, revealing an average target of $31.67, a high estimate of $77.00, and a low estimate of $8.00. Observing a 33.46% increase, the current average has risen from the previous average price target of $23.73.
分析師們爲capricor therapeutics設定了12個月的價格目標，顯示出平均目標爲31.67美元，最高估計爲77.00美元，最低估計爲8.00美元。觀察到33.46%的增長，當前平均價格目標已經從之前的23.73美元上升。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The perception...
金融...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間